<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03511001</url>
  </required_header>
  <id_info>
    <org_study_id>1119341-85085</org_study_id>
    <secondary_id>1SC3GM122628</secondary_id>
    <nct_id>NCT03511001</nct_id>
  </id_info>
  <brief_title>Effects Among Smokers Who Use and Do Not Use E-Cigarettes</brief_title>
  <official_title>Effects Among Smokers Who Use and Do Not Use E-Cigarettes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>California State University, San Marcos</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of General Medical Sciences (NIGMS)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>California State University, San Marcos</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study compares effects among Latino and African American cigarette smokers who use&#xD;
      e-cigarettes with those who continue smoking as usual.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 17, 2018</start_date>
  <completion_date type="Actual">September 26, 2019</completion_date>
  <primary_completion_date type="Actual">May 10, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Toxicant Exposure</measure>
    <time_frame>6 weeks</time_frame>
    <description>Urinary NNAL at week 6. Urinary NNAL measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Carbon Monoxide</measure>
    <time_frame>6 weeks</time_frame>
    <description>Carbon monoxide at week 6. Breath test (PPM)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Respiratory Symptoms</measure>
    <time_frame>6 weeks</time_frame>
    <description>Respiratory symptoms at week 6. American Thoracic Society Questionnaire total score ranges from 0-32; higher scores reflect worse outcomes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lung Function</measure>
    <time_frame>6 weeks</time_frame>
    <description>FEF 25%-75%, L/s at week 6 measured by spirometer</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Systolic Blood Pressure</measure>
    <time_frame>6 weeks</time_frame>
    <description>Systolic blood pressure at week 6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diastolic Blood Pressure</measure>
    <time_frame>6 weeks</time_frame>
    <description>Diastolic blood pressure at week 6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tobacco Dependence</measure>
    <time_frame>6 weeks</time_frame>
    <description>Tobacco dependence at week 6. Validated questions from PATH; total score ranges from 15-76, higher scores reflect worse outcomes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Self-efficacy to Resist Smoking</measure>
    <time_frame>6 weeks</time_frame>
    <description>Self-efficacy to resist smoking at week 6. Brief Self Efficacy to Resist Smoking Cigarettes Scale; total score ranges from 0-60, higher score reflects better outcome</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">187</enrollment>
  <condition>Toxicant Exposure</condition>
  <arm_group>
    <arm_group_label>E-Cigarette</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>6 weeks of JUUL electronic cigarettes</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Assessment Only</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>6 weeks of smoking as usual</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>E-Cigarette Vs. Smoking as Usual</intervention_name>
    <description>6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
    <arm_group_label>Assessment Only</arm_group_label>
    <arm_group_label>E-Cigarette</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  &gt; 21 years of age&#xD;
&#xD;
          -  Smoked cigarettes on &gt; 25 of past 30 days&#xD;
&#xD;
          -  Smoked &gt; 5 cigarettes per day on days smoked&#xD;
&#xD;
          -  Smoked cigarettes &gt; 6 months&#xD;
&#xD;
          -  Carbon monoxide &gt; 5 PPM at baseline&#xD;
&#xD;
          -  Hispanic/Latino or African American/Black&#xD;
&#xD;
          -  Fluent in English or Spanish&#xD;
&#xD;
          -  Willing to switch from smoking cigarettes to ECs for 6 weeks&#xD;
&#xD;
          -  Regular access to telephone&#xD;
&#xD;
          -  Transportation to attend appointments (KC Only)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Primary use of other tobacco products or equal use of cigarettes and other tobacco&#xD;
             products&#xD;
&#xD;
          -  Electronic cigarette use on &gt; 4 of the past 30 days&#xD;
&#xD;
          -  Currently in a smoking cessation program or another clinical trial&#xD;
&#xD;
          -  Use of nicotine replacement therapy or medication which aids smoking cessation in the&#xD;
             past 30 days&#xD;
&#xD;
          -  Hospitalization for a psychiatric issue in the past 30 days&#xD;
&#xD;
          -  Heart-related event in the past 30 days. Examples include heart attack, stroke, severe&#xD;
             angina (i.e. chest pain), ischemic heart disease, and vascular disease&#xD;
&#xD;
          -  Uncontrolled blood pressure at baseline&#xD;
&#xD;
          -  Planning to move out of San Diego or Kansas City in the next 6 weeks&#xD;
&#xD;
          -  Another person in the household enrolled in the study&#xD;
&#xD;
          -  Women: pregnant, breastfeeding, or planning to become pregnant in the next six months&#xD;
&#xD;
          -  Unstable mental status or health status&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kim Pulvers, PhD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Associate Professor</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>California State University San Marcos</name>
      <address>
        <city>San Marcos</city>
        <state>California</state>
        <zip>92096</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Swope Health Central</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 10, 2018</study_first_submitted>
  <study_first_submitted_qc>April 18, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 27, 2018</study_first_posted>
  <results_first_submitted>February 4, 2021</results_first_submitted>
  <results_first_submitted_qc>August 9, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">September 5, 2021</results_first_posted>
  <last_update_submitted>October 8, 2021</last_update_submitted>
  <last_update_submitted_qc>October 8, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>April 23, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/01/NCT03511001/Prot_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>E-Cigarette</title>
          <description>6 weeks of JUUL electronic cigarettes&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
        </group>
        <group group_id="P2">
          <title>Assessment Only</title>
          <description>6 weeks of smoking as usual&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="126"/>
                <participants group_id="P2" count="61"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Completers Analyzed</title>
              <participants_list>
                <participants group_id="P1" count="114">1 participant was excluded post-randomization due to not meeting race/ethnicity inclusion criteria.</participants>
                <participants group_id="P2" count="61"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="115"/>
                <participants group_id="P2" count="54"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="11"/>
                <participants group_id="P2" count="7"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>One post-randomization exclusion from analyses due to not meeting race/ethnicity inclusion criteria</population>
      <group_list>
        <group group_id="B1">
          <title>E-Cigarette</title>
          <description>6 weeks of JUUL electronic cigarettes&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
        </group>
        <group group_id="B2">
          <title>Assessment Only</title>
          <description>6 weeks of smoking as usual&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="125"/>
            <count group_id="B2" value="61"/>
            <count group_id="B3" value="186"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.1" spread="12.7"/>
                    <measurement group_id="B2" value="41.7" spread="11.9"/>
                    <measurement group_id="B3" value="43.3" spread="12.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="49"/>
                    <measurement group_id="B2" value="26"/>
                    <measurement group_id="B3" value="75"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="63"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="94"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="62"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="92"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="12"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="96"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="36"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="60"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="11"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="125"/>
                    <measurement group_id="B2" value="61"/>
                    <measurement group_id="B3" value="186"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>High school education or less</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>200% federal poverty level or lower</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="93"/>
                    <measurement group_id="B2" value="45"/>
                    <measurement group_id="B3" value="138"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Never married</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="59"/>
                    <measurement group_id="B2" value="31"/>
                    <measurement group_id="B3" value="90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Menthol smoker</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="68"/>
                    <measurement group_id="B2" value="34"/>
                    <measurement group_id="B3" value="102"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Duration smoking in years</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="17.5" spread="12.8"/>
                    <measurement group_id="B2" value="15.5" spread="12.5"/>
                    <measurement group_id="B3" value="16.8" spread="12.7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Time to first cigarette 30 minutes or less</title>
          <description>Participants were asked how soon after waking they typically smoked first cigarette of the day. Response options included within 30 minutes of waking or after 30 minutes of waking.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="91"/>
                    <measurement group_id="B2" value="44"/>
                    <measurement group_id="B3" value="135"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Days smoked in past 7 days</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.9" spread="0.5"/>
                    <measurement group_id="B2" value="6.7" spread="0.9"/>
                    <measurement group_id="B3" value="6.8" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Cigarettes per day in past 7 days</title>
          <units>cigarettes per day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="12.4" spread="7.7"/>
                    <measurement group_id="B2" value="11.5" spread="6.1"/>
                    <measurement group_id="B3" value="12.1" spread="7.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Days used e-cigarettes in past 7 days</title>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.03" spread="0.28"/>
                    <measurement group_id="B2" value="0.08" spread="0.33"/>
                    <measurement group_id="B3" value="0.05" spread="0.30"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>E-cigarette uses in past 7 days</title>
          <units>uses per day</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.05" spread="0.48"/>
                    <measurement group_id="B2" value="0.09" spread="0.36"/>
                    <measurement group_id="B3" value="0.06" spread="0.45"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of chronic obstructive pulmonary disorder</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of asthma</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of mental health diagnosis</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="77"/>
                    <measurement group_id="B2" value="30"/>
                    <measurement group_id="B3" value="107"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>History of substance abuse</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="88"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Urine cotinine, ng/mL</title>
          <units>ng/mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="928" lower_limit="463" upper_limit="1476"/>
                    <measurement group_id="B2" value="1061" lower_limit="534" upper_limit="1720"/>
                    <measurement group_id="B3" value="998" lower_limit="480" upper_limit="1653"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Urine NNAL, pg/mL</title>
          <units>pg/mL</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="124" lower_limit="45" upper_limit="197"/>
                    <measurement group_id="B2" value="88" lower_limit="58" upper_limit="197"/>
                    <measurement group_id="B3" value="110" lower_limit="52" upper_limit="197"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Carbon monoxide, ppm</title>
          <units>ppm</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16" lower_limit="11" upper_limit="22"/>
                    <measurement group_id="B2" value="17" lower_limit="11" upper_limit="25"/>
                    <measurement group_id="B3" value="17" lower_limit="11" upper_limit="23"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Lung function, FEF 25%-75%, L/s</title>
          <units>L/s</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3.0" lower_limit="2.1" upper_limit="4.1"/>
                    <measurement group_id="B2" value="2.8" lower_limit="2.1" upper_limit="4.0"/>
                    <measurement group_id="B3" value="3.0" lower_limit="2.1" upper_limit="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Respiratory symptoms, number</title>
          <description>American Thoracic Society Questionnaire total score ranges from 0-32; higher scores reflect worse outcomes</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="11" lower_limit="5" upper_limit="18"/>
                    <measurement group_id="B2" value="8" lower_limit="4" upper_limit="13"/>
                    <measurement group_id="B3" value="10" lower_limit="5" upper_limit="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Systolic blood pressure</title>
          <units>mm Hg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="130" lower_limit="115" upper_limit="142"/>
                    <measurement group_id="B2" value="129" lower_limit="118" upper_limit="140"/>
                    <measurement group_id="B3" value="129" lower_limit="116" upper_limit="142"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Diastolic blood pressure</title>
          <units>mm Hg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="81" lower_limit="76" upper_limit="89"/>
                    <measurement group_id="B2" value="83" lower_limit="74" upper_limit="88"/>
                    <measurement group_id="B3" value="82" lower_limit="76" upper_limit="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Toxicant Exposure</title>
        <description>Urinary NNAL at week 6. Urinary NNAL measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS)</description>
        <time_frame>6 weeks</time_frame>
        <population>Of the 115 participants enrolled in the treatment group, one was excluded post-randomization due to not meeting race/ethnicity inclusion criteria. Total number analyzed in treatment group was 114.</population>
        <group_list>
          <group group_id="O1">
            <title>E-Cigarette</title>
            <description>6 weeks of JUUL electronic cigarettes&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
          </group>
          <group group_id="O2">
            <title>Assessment Only</title>
            <description>6 weeks of smoking as usual&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
          </group>
        </group_list>
        <measure>
          <title>Toxicant Exposure</title>
          <description>Urinary NNAL at week 6. Urinary NNAL measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS)</description>
          <population>Of the 115 participants enrolled in the treatment group, one was excluded post-randomization due to not meeting race/ethnicity inclusion criteria. Total number analyzed in treatment group was 114.</population>
          <units>pg/ml</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="114"/>
                <count group_id="O2" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="40" lower_limit="12" upper_limit="101"/>
                    <measurement group_id="O2" value="97" lower_limit="39" upper_limit="222"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Carbon Monoxide</title>
        <description>Carbon monoxide at week 6. Breath test (PPM)</description>
        <time_frame>6 weeks</time_frame>
        <population>Of the 115 participants enrolled in the treatment group, one was excluded post-randomization due to not meeting race/ethnicity inclusion criteria. Total number analyzed in treatment group was 114.</population>
        <group_list>
          <group group_id="O1">
            <title>E-Cigarette</title>
            <description>6 weeks of JUUL electronic cigarettes&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
          </group>
          <group group_id="O2">
            <title>Assessment Only</title>
            <description>6 weeks of smoking as usual&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
          </group>
        </group_list>
        <measure>
          <title>Carbon Monoxide</title>
          <description>Carbon monoxide at week 6. Breath test (PPM)</description>
          <population>Of the 115 participants enrolled in the treatment group, one was excluded post-randomization due to not meeting race/ethnicity inclusion criteria. Total number analyzed in treatment group was 114.</population>
          <units>ppm</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="114"/>
                <count group_id="O2" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="3" upper_limit="14"/>
                    <measurement group_id="O2" value="16" lower_limit="9" upper_limit="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Respiratory Symptoms</title>
        <description>Respiratory symptoms at week 6. American Thoracic Society Questionnaire total score ranges from 0-32; higher scores reflect worse outcomes</description>
        <time_frame>6 weeks</time_frame>
        <population>Of the 115 participants enrolled in the treatment group, one was excluded post-randomization due to not meeting race/ethnicity inclusion criteria. Total number analyzed in treatment group was 114.</population>
        <group_list>
          <group group_id="O1">
            <title>E-Cigarette</title>
            <description>6 weeks of JUUL electronic cigarettes&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
          </group>
          <group group_id="O2">
            <title>Assessment Only</title>
            <description>6 weeks of smoking as usual&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
          </group>
        </group_list>
        <measure>
          <title>Respiratory Symptoms</title>
          <description>Respiratory symptoms at week 6. American Thoracic Society Questionnaire total score ranges from 0-32; higher scores reflect worse outcomes</description>
          <population>Of the 115 participants enrolled in the treatment group, one was excluded post-randomization due to not meeting race/ethnicity inclusion criteria. Total number analyzed in treatment group was 114.</population>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="114"/>
                <count group_id="O2" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="3" upper_limit="12"/>
                    <measurement group_id="O2" value="9" lower_limit="4" upper_limit="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Lung Function</title>
        <description>FEF 25%-75%, L/s at week 6 measured by spirometer</description>
        <time_frame>6 weeks</time_frame>
        <population>Of the 115 participants enrolled in the treatment group, one was excluded post-randomization due to not meeting race/ethnicity inclusion criteria. Total number analyzed in treatment group was 114.</population>
        <group_list>
          <group group_id="O1">
            <title>E-Cigarette</title>
            <description>6 weeks of JUUL electronic cigarettes&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
          </group>
          <group group_id="O2">
            <title>Assessment Only</title>
            <description>6 weeks of smoking as usual&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
          </group>
        </group_list>
        <measure>
          <title>Lung Function</title>
          <description>FEF 25%-75%, L/s at week 6 measured by spirometer</description>
          <population>Of the 115 participants enrolled in the treatment group, one was excluded post-randomization due to not meeting race/ethnicity inclusion criteria. Total number analyzed in treatment group was 114.</population>
          <units>L/sec</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="114"/>
                <count group_id="O2" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.8" lower_limit="1.8" upper_limit="4.1"/>
                    <measurement group_id="O2" value="2.7" lower_limit="2.1" upper_limit="4.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Systolic Blood Pressure</title>
        <description>Systolic blood pressure at week 6</description>
        <time_frame>6 weeks</time_frame>
        <population>Of the 115 participants enrolled in the treatment group, one was excluded post-randomization due to not meeting race/ethnicity inclusion criteria. Total number analyzed in treatment group was 114.</population>
        <group_list>
          <group group_id="O1">
            <title>E-Cigarette</title>
            <description>6 weeks of JUUL electronic cigarettes&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
          </group>
          <group group_id="O2">
            <title>Assessment Only</title>
            <description>6 weeks of smoking as usual&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
          </group>
        </group_list>
        <measure>
          <title>Systolic Blood Pressure</title>
          <description>Systolic blood pressure at week 6</description>
          <population>Of the 115 participants enrolled in the treatment group, one was excluded post-randomization due to not meeting race/ethnicity inclusion criteria. Total number analyzed in treatment group was 114.</population>
          <units>mmHg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="114"/>
                <count group_id="O2" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="128" lower_limit="117" upper_limit="142"/>
                    <measurement group_id="O2" value="133" lower_limit="122" upper_limit="143"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diastolic Blood Pressure</title>
        <description>Diastolic blood pressure at week 6</description>
        <time_frame>6 weeks</time_frame>
        <population>Of the 115 participants enrolled in the treatment group, one was excluded post-randomization due to not meeting race/ethnicity inclusion criteria. Total number analyzed in treatment group was 114.</population>
        <group_list>
          <group group_id="O1">
            <title>E-Cigarette</title>
            <description>6 weeks of JUUL electronic cigarettes&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
          </group>
          <group group_id="O2">
            <title>Assessment Only</title>
            <description>6 weeks of smoking as usual&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
          </group>
        </group_list>
        <measure>
          <title>Diastolic Blood Pressure</title>
          <description>Diastolic blood pressure at week 6</description>
          <population>Of the 115 participants enrolled in the treatment group, one was excluded post-randomization due to not meeting race/ethnicity inclusion criteria. Total number analyzed in treatment group was 114.</population>
          <units>mmHg</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="114"/>
                <count group_id="O2" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="83" lower_limit="74" upper_limit="89"/>
                    <measurement group_id="O2" value="83" lower_limit="75" upper_limit="89"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Tobacco Dependence</title>
        <description>Tobacco dependence at week 6. Validated questions from PATH; total score ranges from 15-76, higher scores reflect worse outcomes</description>
        <time_frame>6 weeks</time_frame>
        <population>Of the 115 participants enrolled in the treatment group, one was excluded post-randomization due to not meeting race/ethnicity inclusion criteria. Total number analyzed in treatment group was 114.</population>
        <group_list>
          <group group_id="O1">
            <title>E-Cigarette</title>
            <description>6 weeks of JUUL electronic cigarettes&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
          </group>
          <group group_id="O2">
            <title>Assessment Only</title>
            <description>6 weeks of smoking as usual&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
          </group>
        </group_list>
        <measure>
          <title>Tobacco Dependence</title>
          <description>Tobacco dependence at week 6. Validated questions from PATH; total score ranges from 15-76, higher scores reflect worse outcomes</description>
          <population>Of the 115 participants enrolled in the treatment group, one was excluded post-randomization due to not meeting race/ethnicity inclusion criteria. Total number analyzed in treatment group was 114.</population>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="114"/>
                <count group_id="O2" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="18.5" lower_limit="15.0" upper_limit="36.3"/>
                    <measurement group_id="O2" value="41.0" lower_limit="33.8" upper_limit="57.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Self-efficacy to Resist Smoking</title>
        <description>Self-efficacy to resist smoking at week 6. Brief Self Efficacy to Resist Smoking Cigarettes Scale; total score ranges from 0-60, higher score reflects better outcome</description>
        <time_frame>6 weeks</time_frame>
        <population>Of the 115 participants enrolled in the treatment group, one was excluded post-randomization due to not meeting race/ethnicity inclusion criteria. Total number analyzed in treatment group was 114.</population>
        <group_list>
          <group group_id="O1">
            <title>E-Cigarette</title>
            <description>6 weeks of JUUL electronic cigarettes&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
          </group>
          <group group_id="O2">
            <title>Assessment Only</title>
            <description>6 weeks of smoking as usual&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
          </group>
        </group_list>
        <measure>
          <title>Self-efficacy to Resist Smoking</title>
          <description>Self-efficacy to resist smoking at week 6. Brief Self Efficacy to Resist Smoking Cigarettes Scale; total score ranges from 0-60, higher score reflects better outcome</description>
          <population>Of the 115 participants enrolled in the treatment group, one was excluded post-randomization due to not meeting race/ethnicity inclusion criteria. Total number analyzed in treatment group was 114.</population>
          <units>score on a scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="114"/>
                <count group_id="O2" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="43.0" lower_limit="26.5" upper_limit="56.0"/>
                    <measurement group_id="O2" value="20.0" lower_limit="12.5" upper_limit="30.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>6 weeks</time_frame>
      <group_list>
        <group group_id="E1">
          <title>E-Cigarette</title>
          <description>6 weeks of JUUL electronic cigarettes&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
        </group>
        <group group_id="E2">
          <title>Assessment Only</title>
          <description>6 weeks of smoking as usual&#xD;
E-Cigarette Vs. Smoking as Usual: 6 weeks of JUUL e-cigarettes vs. 6 weeks of smoking as usual</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="114"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="114"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="46" subjects_at_risk="114"/>
                <counts group_id="E2" subjects_affected="22" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Rapid Heart Rate</sub_title>
                <counts group_id="E1" events="18" subjects_affected="18" subjects_at_risk="114"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Nauseau and/or Vomiting</sub_title>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="114"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Dizziness</sub_title>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="114"/>
                <counts group_id="E2" events="14" subjects_affected="14" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dry Mouth/Throat</sub_title>
                <counts group_id="E1" events="46" subjects_affected="46" subjects_at_risk="114"/>
                <counts group_id="E2" events="22" subjects_affected="22" subjects_at_risk="54"/>
              </event>
              <event>
                <sub_title>Irritated Mouth/Throat</sub_title>
                <counts group_id="E1" events="24" subjects_affected="24" subjects_at_risk="114"/>
                <counts group_id="E2" events="11" subjects_affected="11" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Kim Pulvers</name_or_title>
      <organization>California State University San Marcos</organization>
      <phone>760 750 4127</phone>
      <email>kpulvers@csusm.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

